This is in response to a letter dated December 21, 2018 we received with respect to the issuer above from the Division of Corporation Finance, Office of Financial Services, without a contact name attached. When she called, my assistant was told that we should forward our response to your attention.

For clarity, we have copied below the comments from theDecember 21^st letter and provided our response below each comment.

Also enclosed are clean and blacklined versions of the Offering Circular and the Operating Agreement reflecting the changes we’ve made in response to your comments.

This letter and the revised documents (but not the blacklined version) have also been filed through EDGAR.

Please revise the cover page of your offering circular to address the following:

Your Comment #2 – Offering Statement – Limitation on Rights in Investment Agreement

We note disclosure on page 6 that the waiver of jury trial provided for in your Investment Agreement does not apply to claims under the federal securities laws, however, this is not reflected in the Investment Agreement filed as Exhibit 1A-4 to your offering statement. We also note that your Operating Agreement contains a similar provision. Please revise your disclosures, as well as the Investment Agreement and Operating Agreement, to clarify that the jury trial waiver provisions appearing in the Investment Agreement and in the Operating Agreement do not apply to claims under the federal securities laws.

Our Response:

Our version of the Investment Agreement does include the language requested. I’m not sure why your doesn’t, but in any event we have re-filed our version as Exhibit 1A-4.

We have also added similar language to the Operating Agreement.

Please revise to state the approximate amount of proceeds from this offering that you intend to use for purchasing mortgages and other assets for the Company, operating costs and management fees.

Our Response:

We have added a table with these estimates.

Your Comment #4 – Summary of Operating Agreement and Authorizing Resolution

We note the LLC Agreement provides that officers, employees, or agents of the Company do not owe any fiduciary duties to the Company or its stockholders, and that any fiduciary duties that may be implied by applicable law are expressly waived by the stockholders (including investors) and the Company. Please revise to clarify whether this limitation applies to claims made under the federal securities laws. Please also confirm that Delaware law permits such a provision, or alternatively address any questions as to enforceability specifically focusing on the enforceability of a provision that extends beyond members and managers. Last, revise to discuss more specifically what rights investors are relinquishing so that investors can fully understand the consequences of this waiver. Please make corresponding revisions to the risk factor “Limitations on Rights in Operating Agreement” on page 6.

Our Response

First, we note that claims arising under the federal securities laws – for example, a claim arising under Rule 10b-5 – have a legal basis other than an alleged breach of a fiduciary obligation, by definition, and are therefore not affected by these provisions in the Operating Agreement. Nevertheless, we have revised the Operating Agreement and the Offering Circular to clarify that these provisions do not apply to claims made under the federal securities laws. We note further that, pursuant to section 18-1101(c) of the Delaware Limited Liability Company Act, the duties (including fiduciary duties) of a member, manager or other person party to or otherwise bound by a Delaware limited liability company operating agreement may be expanded, restricted or eliminated altogether by provisions in the limited liability company operating agreement. Section 18-1101(e) of the Delaware Limited Liability Company Act further provides that the operating agreement may limit or eliminate the liability of any member, manager or other person bound by the operating agreement for breach of fiduciary duty. Finally, we have has revised the disclosures regarding the waiver and elimination of fiduciary duties to further clarify the consequences of such provisions to investors.

Please revise to include the beneficial ownership table specified in Item 12 of Form 1-A. We note your disclosure that your Managing Member will own 100% of the Company’s Common Stock.

Please revise the exhibit index to clarify that Exhibit 1A-6B is a form-of agreement.

Thank you for your continued attention to this matter. Please let me know if you have further questions or need additional information.

	Very truly yours,

	/s/ Markley S. Roderick
	Markley S. Roderick